ViiV Healthcare, which has a large research and development operation in RTP, has filed for approval of an AIDS treatment that would help people infected with HIV who have developed a resistance or intolerance to other medications.
Read More
As people around the world commemorate World AIDS Day, in many countries, the disease is still cutting lives short at an alarming rate. So what’s needed to address this global health issue?
Read More
“Approval of this regimen would mark a significant change in the HIV treatment paradigm,” says the head of R&D at ViiV Healthcare.
Read More
Hundreds of thousands of uninsured people may soon have access to medication meant to curb the HIV epidemic.
Read More
The risk of passing on the HIV virus is completely eliminated by effective drugs treatment, a landmark study has shown, in a significant boost to the prospects of ending the AIDS pandemic. And a UNC professor is hailing the findings.
Read More
ViiV Healthcare, which operates a major research and development operation in RTP, is seeking FDA approval for what it says would be the first long-term injectable HIV treatment that contains two drugs.
Read More
Monthly shots of HIV drugs worked as well as daily pills to control the virus that causes AIDS in two large international tests, researchers reported Thursday. That’s good news for ViiV Healthcare, which has a large operation in RTP.
Read More
Our latest roundup of technology headlines includes: Apple adding jobs in San Diego, AT&T buying spectrum – is it for 5g?; Jeff Bezos and Microsoft invest in fusion energy, and more.
Read More
A London man appears to be free of the AIDS virus after a stem cell transplant, the second success including the “Berlin patient,” doctors reported.
Read More
